What's in Tego Science, Inc.'s pipeline?

Tego Science, Inc. has 3 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Tego Science, Inc.'s portfolio?

Top competitors by shared drug class: Astellas Pharma Europe B.V., Dyve Biosciences, Inc., Pfizer, Shirley Vichy Wang.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/tego-science-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-09 · How we verify

Tego Science, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tego Science, Inc. pipeline: 0 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
TPX-114	TPX-114	phase 3	CDK inhibitor	CDK9	Oncology
TPX-105	TPX-105	phase 3	TRP channel inhibitor	TRP channels (specific subtype proprietary to Tego Science)	Pain Management

Therapeutic area mix

Oncology · 1
Pain Management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Astellas Pharma Europe B.V. · 1 shared drug class
Dyve Biosciences, Inc. · 1 shared drug class
Pfizer · 1 shared drug class
Shirley Vichy Wang · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Tego Science, Inc.:

Cite this brief

Drug Landscape (2026). Tego Science, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/tego-science-inc. Accessed 2026-06-09.